Skip to main content
OpenTrials
Completed

NCT Number: NCT05150353

Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP)

This study is based on the hypothesis that MRI could make it possible to non-invasively detect these amyloid deposits at the level of the wrist using parametric sequences known as T1 mapping, in the form of an extension of T1 in the wrists. areas where amyloid deposits are found in the wrist.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient group:

  • Woman or man over 18 years old
  • With ATTR or AL cardiac amyloidosis with or without carpal tunnel. The diagnosis of amyloidosis must be proven by a positive myocardial biopsy or diphosphonate scintigraphy.
  • Affiliate or beneficiarie of a social security scheme.
  • Having signed the free and informed consent.

Healthy volunteers:

  • Woman or man over 18 years old
  • Affiliate or beneficiarie of a social security scheme.
  • Having signed the free and informed consent.

Exclusion criteria

Patient group:

  • Patients participating in another clinical study.
  • Patients suffering from rheumatoid arthritis or other autoimmune disease (vasculitis, lupus, scleroderma, etc.)
  • Patients with a medical history of wrist surgery (exclude the operated side).
  • Patients with a contraindication to performing an MRI (pacemaker, etc.)
  • Pregnant or breastfeeding women.
  • Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision.

Healthy volunteer:

  • Volunteers participating in another clinical study.
  • Volunteers suffering from rheumatoid arthritis or other autoimmune disease (vasculitis, lupus, scleroderma, etc.)
  • Pregnant or breastfeeding women.
  • Volunteer with a contraindication to performing an MRI (pacemaker, etc.)
  • Protected volunteers: Adults under guardianship, guardianship or other legal protection, deprived of their liberty by judicial or administrative decision.

Treatment and study plan

MRI

Procedure

Wrist MRI

Primary outcomes

  1. T1 measurement (ms) associated with each of the 5 regions of interest at the wrist

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Other

Collaborators

  • European Clinical Trial Experts Network

Registry information

Official study title

Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis

Acronym: AMYLOCARP

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Dec 9, 2021
Registry last updated
Jul 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.